华神科技 (000790)
Chengdu huasun technology group Inc., Ltd
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 62371.94
- Circulating A-Shares(W): 62261.46
- Earnings Per Share(RMB): -0.1568
- Net Assets Per Share(RMB): 1.4948
- Operating Revenue(W RMB): 45738.46
- Total Profit(W RMB): -9294.17
- Net Profit Attributable to Parent(W RMB): -9778.53
- Net Profit Growth Rate(%): -1804.21
- Weighted Return on Equity(%): -10.0100
- Operating Cash Flow Per Share(RMB): -0.0170
- Undistributed Profit Per Share(RMB): 0.1894
- Capital Reserve Per Share(RMB): 0.1063
2. Main Business
The main business covers:
- R&D, production, and sales of Chinese and Western patent medicines
- R&D, production, and sales of biopharmaceuticals
- R&D, production, and sales of big health products
- Steel structure construction business
3. Company Basic Information
- Company Name: Chengdu Huasun Technology Group Inc., Ltd.
- Listing Date: 1998-03-27
- Industry: Pharmaceutical Manufacturing
- Address: No. 1168, Shuxin Avenue, High-tech Zone (West District), Chengdu, Sichuan Province, China
- Website: www.huasungrp.com
- Company Profile: The company was jointly established in March 1988 by three entities including Chengdu Youth Management and Construction Joint Company. Initially, the founders' monetary capital investment was converted into 16.32 million legal person shares. After issuing 17 million public shares on its own in January 1990 and raising 32.68 million legal person shares in September 1992, the total share capital at the time of listing was 66 million shares. Its 17 million public shares were listed and traded on the Shenzhen Stock Exchange on March 27, 1998.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Sichuan Huasun Group Co., Ltd. | General Legal Person | 11143.13 | 17.90 |
| 2 | ChinaAMC CSI Traditional Chinese Medicine ETF | Fund | 388.60 | 0.62 |
| 3 | Lion Multi-Strategy Hybrid Securities Investment Fund Class A | Fund | 347.56 | 0.56 |
| 4 | ||||
| 5 | ||||
| 6 | ||||
| 7 | ||||
| 8 | ||||
| 9 | ||||
| 10 |
5. Concept Sectors
- Lithium Battery
- Generic Drugs
- Fluorine Concept
- Medical Aesthetics Concept
- CXO Concept
- Prefabricated Construction
- Innovative Drugs
- Synthetic Biology
- Margin Trading & Securities Lending
- Micro-cap Stocks
- Consecutive Losses
- Goodwill Impairment
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information